Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lianping Xing

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
Regulation of osteoclast precursors in inflammatory bone lossLianping Xing
Clinical Investigation|March 3, 2012
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical dataBrendan Boyce, Lianping Xing
Stem Cells (Dayton, Ohio)|April 23, 2013
Ubiquitin e3 ligase itch negatively regulates osteoblast differentiation from mesenchymal progenitor cellsHengwei Zhang, Lianping Xing
Biochemical and Biophysical Research Communications|February 8, 2005
Regulation of apoptosis in osteoclasts and osteoblastic cellsLianping Xing, Brendan F Boyce
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2014
RANKL-based osteoclastogenic assays from murine bone marrow cellsLianping Xing, Brendan F Boyce
Current Osteoporosis Reports|October 11, 2007
The RANKL/RANK/OPG pathwayBrendan F Boyce, Lianping Xing
Arthritis Research & Therapy|July 20, 2007
Biology of RANK, RANKL, and osteoprotegerinBrendan F Boyce, Lianping Xing
Cell Metabolism|April 9, 2008
Bruton and Tec: new links in osteoimmunologyBrendan F Boyce, Lianping Xing
Expert Review of Clinical Immunology|May 19, 2010
Lymphangiogenesis, myeloid cells and inflammationLianping Xing, Rui-Cheng Ji
Nature Medicine|December 8, 2006
Osteoclasts, no longer osteoblast slavesBrendan F Boyce, Lianping Xing
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
Regulation of osteoclast precursors in inflammatory bone lossLianping Xing
Clinical Investigation|March 3, 2012
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical dataBrendan Boyce, Lianping Xing
Stem Cells (Dayton, Ohio)|April 23, 2013
Ubiquitin e3 ligase itch negatively regulates osteoblast differentiation from mesenchymal progenitor cellsHengwei Zhang, Lianping Xing
Biochemical and Biophysical Research Communications|February 8, 2005
Regulation of apoptosis in osteoclasts and osteoblastic cellsLianping Xing, Brendan F Boyce
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2014
RANKL-based osteoclastogenic assays from murine bone marrow cellsLianping Xing, Brendan F Boyce
Current Osteoporosis Reports|October 11, 2007
The RANKL/RANK/OPG pathwayBrendan F Boyce, Lianping Xing
Arthritis Research & Therapy|July 20, 2007
Biology of RANK, RANKL, and osteoprotegerinBrendan F Boyce, Lianping Xing
Cell Metabolism|April 9, 2008
Bruton and Tec: new links in osteoimmunologyBrendan F Boyce, Lianping Xing
Expert Review of Clinical Immunology|May 19, 2010
Lymphangiogenesis, myeloid cells and inflammationLianping Xing, Rui-Cheng Ji
Nature Medicine|December 8, 2006
Osteoclasts, no longer osteoblast slavesBrendan F Boyce, Lianping Xing
Pageof 16